Pancragen Peptide (20mg) Description
Pancragen Peptide (20mg) is a targeted bioregulator for pancreatic research applications. This tetrapeptide targets pancreatic cell function studies, including glucose metabolism and endocrine pathway investigations.
Research initiated by Khavinson reveals Pancragen’s selective effects on pancreatic function in laboratory settings. The peptide bioregulator benefits metabolic research protocols examining insulin pathways.
Each batch undergoes thorough testing to meet research standards. Lyophilized formulation maintains stability for pancreatic cell culture applications. Research use only.
Pancragen Peptide (20mg) Information
| Property | Value |
|---|---|
| Peptide Sequence | H-Lys-Glu-Asp-Trp-OH |
| Molecular Formula | C₂₆H₃₆N₆O₉ |
| Molecular Weight | 576.25 g/mol |
| PubChem CID | 68452887 |
Lyophilized Peptides:
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.
Reviews
There are no reviews yet.